QA: Seelos Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2018_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 6,592,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 79,000
3 remainder_Assets 35,000
4 LiabilitiesCurrent 1,583,000
5 LiabilitiesNoncurrent 58,000
6 remainder_Liabilities 694,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,685,961
9 ResearchAndDevelopmentExpense 3,738,120
10 remainder_Expenses 550,564
11 remainder_Revenues 2,480,396
12 remainder_NetIncome 10,279,771
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 6,706,000
1 Liabilities 2,335,000
2 Expenses 10,974,645
3 Revenues 2,480,396
4 StockholdersEquity 4,371,000
5 NetIncome 1,785,522
6 ComprehensiveNetIncome 1,785,522
7 BaseVar 16,387,906
8 EconomicCapitalRatiobeforeLimitedLiability 2.50
9 EconomicCapitalRatio 3.36

Edgar->Model Mapping

Feature Distribution

Change over Time